Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 / 抑制剂/激动剂 / G蛋白偶联受体/G蛋白 / 内皮素受体 / Sitaxsentan sodium

Sitaxsentan sodium {[allProObj[0].p_purity_real_show]}

货号：A180363 同义名： TBC11251 sodium;IPI 1040 sodium

Sitaxsentan sodium has selectory antagonism of endothelin A (ETA) receptor with the IC50 and Ki value of 1.4 nM and 0.43 nM respectively.

Sitaxsentan sodium 化学结构 CAS号：210421-74-2
Sitaxsentan sodium 化学结构
CAS号：210421-74-2
Sitaxsentan sodium 3D分子结构
CAS号：210421-74-2
Sitaxsentan sodium 化学结构 CAS号：210421-74-2
Sitaxsentan sodium 3D分子结构 CAS号：210421-74-2
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Sitaxsentan sodium 纯度/质量文件 产品仅供科研

货号：A180363 标准纯度： {[allProObj[0].p_purity_real_show]}
批次查询： 批次纯度:

全球学术期刊中引用的产品

• Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
• JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
• BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
• J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
• PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >
产品名称 ET-A ↓ ET-B ↓ 其他靶点 纯度
BQ-123 +++

Endothelin A receptor, IC50: 7.3 nM

 		98%
Macitentan ++++

ET-A, IC50: 0.5 nM

 		+

ET-B, IC50: 391 nM

 		98%
Zibotentan ++

ET-A, IC50: 21 nM

 		99%+
Bosentan hydrate +++

ET-A, Ki: 4.7 nM

 		++

ET-B, Ki: 95 nM

 		98%
Ambrisentan ✔ 98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Sitaxsentan sodium 生物活性

描述 G protein-coupled receptor (GPCR) agonists through their receptors can transactivate protein tyrosine kinase receptors such as epidermal growth factor receptor and serine/threonine kinase receptors most notably transforming growth factor (TGF)-β receptor (TβRI). Several GPCR agonists such as Ang II, thrombin, ET-1 can mediate the transactivation of a multitude of protein tyrosine kinase receptors[3]. Endothelin-1 (ET-1) is a potent vasoconstrictor peptide thought to play a critical role in the pathogenesis and progression of PAH. The biological effects of ET-1 are mediated through the endothelin receptor subtype A (ETA) and endothelin receptor subtype B (ETB). Sitaxsentan Sodium is an ETA-selective endothelin receptor antagonists (ERAs) with IC50 value of 1.4 nM[4]. Patients with New York Heart Association (NYHA) functional class II-IV PAH treated with 100 mg sitaxsentan showed statistically significant improvements in 6-minute walk distance (6MWD) (35 m placebo corrected improvement, p<0.01) and 29% of the sitaxsentan 100-mg patients improved by at least one functional class without any deteriorations[5].

Sitaxsentan sodium 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00593905 - Unknown July 2013 United States, Pennsylvania ... 展开 >> Allegheny General Hospital Recruiting Pittsburgh, Pennsylvania, United States, 15212 Contact: Andrea L Nowicki, BA    412-359-3653    anowicki@wpahs.org    Contact: Raymond L Benza, MD    412.359.3584    rbenza@wpahs.org    Principal Investigator: Raymond L Benza, MD 收起 <<
NCT00810732 Chronic Kidney Disease ... 展开 >> CRD 收起 << Phase 2 Completed - United Kingdom ... 展开 >> Pfizer Investigational Site Edinburgh, Scotland, United Kingdom, EH4 2XU 收起 <<
NCT00796666 Pulmonary Arterial Hypertensio... 展开 >>n Pulmonary Hypertension 收起 << Phase 3 Terminated(Safety Issue The tr... 展开 >>ial was prematurely terminated on Dec 9, 2010, due to safety concerns, specifically new emerging evidence of hepatic injury.) 收起 << - -

Sitaxsentan sodium 参考文献

[1]Tilton RG, Munsch CL, et al. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist. Pulm Pharmacol Ther. 2000;13(2):87-97.

[2]Wu C, Chan MF, et al. Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist. J Med Chem. 1997 May 23;40(11):1690-7.

[3]Sharifat N, Mohammad Zadeh G, Ghaffari MA, Dayati P, Kamato D, Little PJ, Babaahmadi-Rezaei H. Endothelin-1 (ET-1) stimulates carboxy terminal Smad2 phosphorylation in vascular endothelial cells by a mechanism dependent on ET receptors and de novo protein synthesis. J Pharm Pharmacol. 2017 Jan;69(1):66-72. doi: 10.1111/jphp.12654. Epub 2016 Dec 1. PMID: 27905105.

[4]Wu C, Decker ER, Blok N, Li J, Bourgoyne AR, Bui H, Keller KM, Knowles V, Li W, Stavros FD, Holland GW, Brock TA, Dixon RA. Acyl substitution at the ortho position of anilides enhances oral bioavailability of thiophene sulfonamides: TBC3214, an ETA selective endothelin antagonist. J Med Chem. 2001 Apr 12;44(8):1211-6. doi: 10.1021/jm000349x. PMID: 11312921.

[5]Waxman AB. A review of sitaxsentan sodium in patients with pulmonary arterial hypertension. Vasc Health Risk Manag. 2007;3(1):151-7. PMID: 17583185; PMCID: PMC1994033.

Sitaxsentan sodium 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.10mL

0.42mL

0.21mL

10.48mL

2.10mL

1.05mL

20.97mL

4.19mL

2.10mL

Sitaxsentan sodium 技术信息

CAS号210421-74-2
分子式C18H14ClN2NaO6S2
分子量 476.89
别名 TBC11251 sodium;IPI 1040 sodium;Thelin;TBC 11251;Sitaxentan (sodium salt)
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Inert atmosphere,Store in freezer, under -20°C
溶解度

DMSO: 105 mg/mL(220.18 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

H2O: 100 mg/mL(209.69 mM)，配合低频超声助溶
动物实验配方

Tags: Sitaxsentan | 210421-74-2 | IPI 1040 | TBC11251 | IPI1040 | IPI-1040 | TBC 11251 | Endothelin Receptor Inhibitor | GPCR/G Protein | Endothelin Receptor | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Sitaxsentan sodium 纯度/质量文件 | Sitaxsentan sodium 亚型比较 | Sitaxsentan sodium 生物活性 | Sitaxsentan sodium 临床数据 | Sitaxsentan sodium 参考文献 | Sitaxsentan sodium 实验方案 | Sitaxsentan sodium 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z